ResMed to Report Second Quarter Fiscal 2021 Earnings on January 28, 2021
January 07 2021 - 3:05PM
Business Wire
ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release
financial and operational results for the second quarter of fiscal
year 2021 on Thursday, January 28, 2021, after the New York Stock
Exchange closes. Following the release, ResMed management will host
a webcast to discuss these results. Other forward-looking and
material information may also be discussed during this webcast.
Earnings webcast details:
•
Location:
http://investor.resmed.com
•
Date:
Thursday, January 28, 2021
•
Time:
1:30 p.m. PST / 4:30 p.m. EST
•
International:
London, Thursday, January 28, 9:30 p.m.
GMT
Sydney, Friday, January 29, 8:30 a.m.
AEDT
Please note that ResMed does not use outside phone lines to
access the earnings call.
A replay of the earnings webcast will be accessible on ResMed’s
website and available approximately two hours after the webcast. In
addition, a phone replay will be available approximately two hours
after the webcast and will be accessible from January 28 until
February 11 at:
- U.S.: +1 800.585.8367
- International: +1 416.621.4642
- Conference ID: 4291663
About ResMed
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions
that treat and keep people out of the hospital, empowering them to
live healthier, higher-quality lives. Our digital health
technologies and cloud-connected medical devices transform care for
people with sleep apnea, COPD, and other chronic diseases. Our
comprehensive out-of-hospital software platforms support the
professionals and caregivers who help people stay healthy in the
home or care setting of their choice. By enabling better care, we
improve quality of life, reduce the impact of chronic disease, and
lower costs for consumers and healthcare systems in more than 140
countries. To learn more, visit ResMed.com and follow @ResMed.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210107005109/en/
For investors Amy Wakeham +1 858.836.5000
investorrelations@resmed.com
For media Jayme Rubenstein +1 858.836.6798
news@resmed.com
Resmed (ASX:RMD)
Historical Stock Chart
From Oct 2024 to Nov 2024
Resmed (ASX:RMD)
Historical Stock Chart
From Nov 2023 to Nov 2024